These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 34220923)

  • 1. A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
    Zhang Y; Chen P; Zhou Q; Wang H; Hua Q; Wang J; Zhong H
    Front Genet; 2021; 12():570336. PubMed ID: 34220923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
    Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma.
    Long J; Zhang S; Zeng X; Ouyang Y; Wang Y; Hu Z; Ye Y; Wu W; Jin F; Zhou S; Zeng Z
    Front Mol Biosci; 2020; 7():586344. PubMed ID: 33330624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
    Song D; Tian J; Han X; Li X
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-related genes have prognostic significance in head and neck squamous cell carcinoma.
    Yang J; Xie K; Li C
    Life Sci; 2020 Sep; 256():117906. PubMed ID: 32504750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a novel hypoxia-related signature for prognostic and immunogenic evaluation in head and neck squamous cell carcinoma.
    Li SR; Man QW; Liu B
    Front Oncol; 2022; 12():943945. PubMed ID: 36452497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma.
    Huang C; Liang Y; Dong Y; Huang L; Li A; Du R; Huang H
    Front Cell Dev Biol; 2022; 10():884590. PubMed ID: 36081907
    [No Abstract]   [Full Text] [Related]  

  • 8. Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes.
    Ren Z; Zhang L; Ding W; Luo Y; Shi Z; Shrestha B; Kan X; Zhang Z; Ding J; He H; Hu X
    Genomics; 2021 Jan; 113(1 Pt 2):1166-1175. PubMed ID: 33227411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
    Liu J; Lu J; Li W
    BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive immunogenomic landscape analysis of prognosis-related genes in head and neck cancer.
    Li L; Wang XL; Lei Q; Sun CZ; Xi Y; Chen R; He YW
    Sci Rep; 2020 Apr; 10(1):6395. PubMed ID: 32286381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
    Zhao X; Cui L
    J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma.
    Qiu Y; Cui L; Lin Y; Gao B; Li J; Zhao X; Zhu X; Hu S; Lin L
    Front Oncol; 2020; 10():1502. PubMed ID: 33224866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of immune inflammation in head and neck squamous cell carcinoma: Tumor microenvironment, drug resistance, and clinical outcomes.
    Zhu L; Wang Y; Yuan X; Ma Y; Zhang T; Zhou F; Yu G
    Front Genet; 2022; 13():1085700. PubMed ID: 36579330
    [No Abstract]   [Full Text] [Related]  

  • 15. Peripheral immune signature resembles tumor microenvironment and predicts clinical outcomes in head and neck squamous cell carcinoma.
    Hu Z; Zhou J; Li Y; Luan Y; Li H; Jia B; Xie Z; Cheng B; Wu T
    Front Immunol; 2022; 13():915207. PubMed ID: 36148222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation-Related Gene Signature for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma.
    Lu Y; Jia Z
    Int J Gen Med; 2022; 15():4793-4805. PubMed ID: 35592543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma.
    She Y; Kong X; Ge Y; Yin P; Liu Z; Chen J; Gao F; Fang S
    Cancer Cell Int; 2020; 20():22. PubMed ID: 31988638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an immune-related signature as a prognostic classifier for patients with early-stage head and neck squamous cell carcinoma.
    Wang L; Zhang Y; Li H; Peng J; Gao C; Yu Q; Gao P; Li L; Chen K; Ye F
    Transl Cancer Res; 2024 Mar; 13(3):1367-1381. PubMed ID: 38617526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
    Chen F; Gong X; Xia M; Yu F; Wu J; Yu C; Li J
    Front Oncol; 2022; 12():857994. PubMed ID: 35619896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of neurotrophic factor-related genes signature in HNSCC to predict survival and immune landscapes.
    Peng G; Chi H; Gao X; Zhang J; Song G; Xie X; Su K; Song B; Yang J; Gu T; Li Y; Xu K; Li H; Liu Y; Tian G
    Front Genet; 2022; 13():1010044. PubMed ID: 36406133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.